SCHEMBL27434015

SCHEMBL27434015

CCN1CCOc2c1cc(Cl)c(F)c2C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 3/20 0.37
CHRM5 P08912 1/20 0.37
CHRM3 P20309 1/20 0.37
PTGER3 P43115 3/20 0.36
NOTUM Q6P988 1/20 0.36
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NR3C1 P04150 1/20 0.34
PGR P06401 1/20 0.34
AR P10275 1/20 0.34
EGFR P00533 1/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
HPGD P15428 1/20 0.32
CASP1 P29466 1/20 0.32
CYP2C19 P33261 1/20 0.32
ACKR3 P25106 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30954157 1.00 CHRM1 (0.37) CHRM1CHRM5CHRM3PTGER3NOTUM
SCHEMBL27434163 0.90 AR (0.36) CHRM1CHRM5CHRM3NOTUMLMNA
SCHEMBL30954145 0.90 AR (0.36) CHRM1CHRM5CHRM3NOTUMLMNA
SCHEMBL30954142 0.88 CHRM5 (0.38) CHRM1CHRM5CHRM3PTGER3NOTUM
SCHEMBL27434007 0.88 CHRM5 (0.38) CHRM1CHRM5CHRM3PTGER3NOTUM
SCHEMBL27434074 0.85 AR (0.41) NOTUMTSHRARKDM4ECYP1A2
SCHEMBL27434272 0.84 TSHR (0.34) CHRM1CHRM5CHRM3NOTUMLMNA
SCHEMBL30954047 0.84 TSHR (0.34) CHRM1CHRM5CHRM3NOTUMLMNA
SCHEMBL30954073 0.84 HSP90AA1 (0.35) NOTUMLMNAMAPTTSHRSMN1; SMN2
SCHEMBL27433875 0.84 HSP90AA1 (0.35) NOTUMLMNAMAPTTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP claimed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO claimed
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed